NASDAQ, TSX: NVCN VANCOUVER, Sept. 1, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) reported today, in a non-precedential opinion, a panel of the United States Court of Appeals for the Federal Circuit affirmed the judgment of the United States District Court for...
Read MoreNASDAQ, TSX: NVCN VANCOUVER, Aug. 10, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced financial results for the second quarter ended June 30, 2017 (all figures in U.S. dollars unless otherwise indicated). "For both the Tiara and Reducer, the quarter saw consistent progress...
Read MoreNASDAQ, TSX: NVCN VANCOUVER, Aug. 3, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that it will release its financial results for the second quarter 2017 on Thursday, August 10, 2017, after markets close. The Company will subsequently hold a conference call...
Read MoreNASDAQ, TSX: NVCN VANCOUVER, June 16, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) reported today that the District Court in Munich, Germany has partially found in favour of Edwards Lifesciences Corporation (formerly CardiAQ Valve Technologies Inc.) ("CardiAQ"), in its case against...
Read MoreNASDAQ, TSX: NVCN VANCOUVER, June 15, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced its Tiara™ technology, developed to treat severe Mitral Regurgitation (MR), is being featured in a video recorded procedure to be presented at the 10th Annual Transcatheter...
Read MoreNASDAQ, TSX: NVCN VANCOUVER, June 13, 2017 /CNW/- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on June 13, 2017 in Vancouver, B.C. (the "Meeting")....
Read MoreNASDAQ, TSX: NVCN VANCOUVER, June 12, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) a specialty medical device company today announced that Alexei Marko, chief executive officer is scheduled to present at the JMP Securities Life Sciences Conference being held at the St....
Read MoreNASDAQ, TSX: NVCN VANCOUVER, May 10, 2017 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced financial results for the first quarter ended March 31, 2017 (all figures in U.S. dollars unless otherwise indicated). "It was another quietly successful quarter," commented Neovasc CEO, Alexei...
Read More